DIANA MCFARLANE: Open Payments
NPI 1336113885 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$44,398 in 53 payments from 5 companies in 2025. Trend: 2023 $1,888 · 2024 $48,390 · 2025 $44,398
Consulting: $31,750Speaker / faculty: $6,500Travel & lodging: $3,413Food & beverage: $2,734
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 34 | $36,488 |
| Ardelyx, Inc. | 16 | $7,770 |
| Ferring Pharmaceuticals Inc. | 1 | $78 |
| GENZYME CORPORATION | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: IBSRELA, REBYOTA, DUPIXENT.
Industry payments across WA — which companies pay providers there.
